Position in GERN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$937,043
-$106,107 QoQ
Shares Held
732,065
+4.6% QoQ
Ownership
0.114%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 259 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 21%
Shared 0%
None 79%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. GERN ranks #139 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in GERN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $937,043 | 732,065 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,043,150 | 700,101 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $960,315 | 727,512 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,147,584 | 837,653 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,232,189 | 873,893 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,334,735 | 839,456 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $2,955,347 | 834,844 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $3,735,393 | 822,774 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,590,296 | 846,768 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $2,399,819 | 727,218 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,496,291 | 709,143 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,496,690 | 705,986 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,272,342 | 707,895 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,242,622 | 572,637 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,229,856 | 508,205 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,169,080 | 499,607 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $722,763 | 466,299 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $478,495 | 351,835 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $474,400 | 388,853 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $536,090 | 391,307 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $539,043 | 382,300 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $674,607 | 426,967 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $701,182 | 440,995 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $634,456 | 364,630 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $683,007 | 313,306 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $356,100 | 299,244 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||